ph: 09 535 7218

Back to Blog

Pelvic Ultrasound Funding

Suspected retained products of conception beyond Section 88 funded scan time period. Persistent, heavy PV bleeding lasting more than 2 weeks following miscarriage or termination of pregnancy, or more than 6 weeks post-delivery, to rule out retained products of conception. For persistent but lighter bleeding a scan should be requested under Access to Diagnostics or via e-referral to radiology. Note that women within 2 weeks of miscarriage or termination of pregnancy, or within 6 weeks of delivery...

November 7, 2018

Rivaroxaban funding

In line with the Auckland Regional HealthPathway, when there is a delay in obtaining community ultrasound for DVT, Enoxaparin continues to be the medication to be administered and funded through POAC. The issue of using rivaroxaban instead of enoxaparin for anticoagulation coverage whist awaiting ultrasound for DVT was considered when the pathways were updated upon the PHARMAC funding of rivaroxaban. However, rivaroxaban use for this indication would be off licence and is not recommended by the ...

September 17, 2018

DVT Risk Stratification

A reminder that the first action for suspected DVT is completion of Wells Score. ONLY if <2 is a d-dimer required.  If score is 2 or more then proceed directly to request for ultrasound. Awaiting d-dimer delays the ultrasound request and this may not be necessary For full details, see the DVT pathway NB: If you are unable to login to Auckland HealthPathways site, please contact POAC 09 535 7218...

June 27, 2018

Antibiotics in sore throat and tonsilitis

Background In patients at low risk of rheumatic fever, antibiotics should only be prescribed if the patient is severely unwell. ≥ 70% of sore throats will be viral and do not need antibiotic treatment. For risk stratification and management of sore throat see sore throat and tonsilitis Where antibiotics are required they should be administered in accordance with the Heart Foundation guideline. Consideration should be given to the use of antibiotic syrup and an antiemetic if the patient is...

June 8, 2018

POAC Cellulitis Management Funding Policy

POAC aligns its funding with the best practice recommendations contained within the Auckland Regional HealthPathways. These recommendations have been agreed by primary care clinicians and hospital specialists across the metro Auckland region. This includes Infectious Diseases, Medical Specialists and the regional Antimicrobial Stewardship Group....

January 31, 2018

IV antibiotics for paediatric Cellulitis

The IV antibiotics for Paediatric Cellulitis guidelines are now up on the live HealthPathways site here.Intravenous antibioticsFor cellulitis, consider intravenous antibiotics administered in the community for children aged ≥ 10 years who are stable but not responding to oral antibiotics (review full pathway for details). This is funded by POAC.  Review exclusion criteria and if uncertain, seek paediatric advice.Treatment:IV ceftriaxone 50 mg/kg/dos...

November 22, 2017

Hepatitis C Treatment Primary Care Reimbursement

Funding has been allocated for the provision of integrated Hepatitis C Services.  The Primary Options for Acute Care (POAC) service will be the mechanism for distributing the funding to GPs across Auckland Metro who provide Hepatitis C treatment in a primary care setting. GP Reimbursement A single extended consult per patient can be claimed up to the total amount of $115.00 (including GST).  There is to be no patient co-payment charged.  Payment for treatment of Hepatitis C by a...

July 10, 2017

Opioid Substitution Therapy Funding

From 1 May 2017 authorised GPs who provide Opioid Substitution Treatment (OST) to patients can claim a reimbursement for a fixed number of patient/GP visits per year. This service is only for patients who are identified as stable and suitable to receive this care from an authorised GP by the Community Alcohol and Drug Service (CADS)/Auckland Opioid Treatment Service (AOTS).The Auckland metro DHBs have agreed to fund :4.5 (four and one half) visits per patient/service user, per year, for those on...

May 31, 2017

New Adult Dehydration Guideline

A new clinical guideline has been developed to support management of acute adult dehydration in primary care. This has been developed by a group of primary care practitioners and specialists in the field to provide guidance with respect to the management of adult dehydration. If you wish to provide any feedback on this guideline, we would love to hear from you - submit this here...

August 12, 2015 Posts 26-34 of 34 | Page prev

This product has been added to your cart